论文部分内容阅读
前列腺癌是最常见的导致男性死亡的恶性肿瘤之一,雄激素剥夺疗法(ADT)是对晚期前列腺癌患者的标准治疗方法。ADT疗法包括性激素释放激素拮抗剂和睾丸切除手术两种,对晚期前列腺癌具有显著的治疗效果。可提高晚期前列腺癌放疗后、伴有淋巴结转移、已行前列腺根治术及腹腔淋巴结清扫术的患者的生存期,也可用于治疗前列腺切除术后、放疗后复发的患者。随着患者生存期的延长,ADT降低骨密度(BMD)和
Prostate cancer is one of the most common malignant tumors that cause men’s death and androgen deprivation therapy (ADT) is the standard treatment for patients with advanced prostate cancer. ADT therapy, including sex hormone releasing hormone antagonists and orchiectomy surgery two, for advanced prostate cancer has a significant therapeutic effect. Can improve the survival of patients with advanced prostate cancer after radiotherapy, with lymph node metastasis, radical prostatectomy and abdominal lymph node dissection of patients with survival, can also be used to treat patients after prostatectomy, recurrence after radiotherapy. ADT decreases bone mineral density (BMD) with prolonged patient survival